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Abstract: Sponges are important components of the Persian Gulf animal communities. The marine sponges of the 
genus Axinella sinoxea is are a genus of sponges in the family Axinellidae. Species of Axinella sinoxea occur in the 
India, Pacific Oceans and also Persian Gulf. Chronic lymphocytic leukemia (CLL) is a disease characterized by the 
relentless accumulation of CD5
+
 B lymphocytes. CLL is the most common leukemia in adults, about 25–30% of all 
leukemias. In this study B lymphocytes mitochondria (both cancerous and non-cancerous) were isolated using 
differential centrifugation from peripheral blood samples and succinate dehydrogenase activity, mitochondrial reactive 
oxygen species (ROS) production, collapse of mitochondrial membrane potential (MMP), mitochondrial swelling and 
finally release of cytochrome C were examined following the addition of methanolic extract of Axinella sinoxea. Our 
results showed that only in mitochondria isolated from cancerous BUT NOT normal lymphocytes a significant (P < 0.05) 
increase in mitochondrial ROS formation, MMP collapse, mitochondrial swelling and cytochrome c release. These results 
showed that Axinella sinoxea extract has a selective toxicity on chronic lymphocytic leukemia lymphocytes and their 
mitochondria and hence may be considered as a promising anti CLL candidate for further studies needed as a 
supplement for cancer patients in the future.  
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1. INTRODUCTION  
Marine organisms have shown to be potential 
sources of bioactive compounds with pharmacological 
effect [1]. With bryozoans, tunicates and sponges being 
the most promising marine organisms as sources of 
new active compounds for drug development [2]. 
Because of their prevalence, ease of collection and 
ability to biosynthesize an array of structurally diverse 
natural products, marine sponges have been the 
primary source of biologically active marine natural 
products [3]. The initial study on the sponge 
nucleosides spongouridine and spongothymidine in the 
marine sponge Cryptotethia crypta played a major role 
in promoting the search for marine bioactive molecules  
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[4]. In the recent years, marine natural products 
bioprospecting has yielded a considerable number of 
drug candidates, most still being in preclinical or early 
clinical development, with only a limited number 
already in the market [5]. Among these, several 
anticancer agents derived from marine sources 
especially sponges have entered preclinical and clinical 
[6-8]. These compounds (Cytarabine, Halichondrin B, 
Bryostatin1, Dolastatin 10 and Ecteinascidin 743) have 
shown cytotoxic activity against various tumor types 
(leukemia and lymphoma) [9]. Cancer, as one of the 
most important diseases in humans, has always 
attracted the scientific and commercial communities 
with an effort of continuously discovering new 
anticancer agents from natural products sources [10]. 
Chronic lymphocytic leukemia (CLL), is a low-grade B-
cell malignancy [11] identified by the gradual 
accumulation of a monoclonal population of 
CD5
+
CD19
+
 B lymphocytes [12]. Clinically, the CLL is 
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very heterogeneous that some patients may live for 
many years, while others may rapidly die of 
progressive and chemotherapy-resistant forms of CLL. 
At present, there is no effective cure for CLL, and thus 
novel therapies have been urgently demanded for 
these patients with poor prognosis [13]. Apoptotic 
mode of death is mainly characterized by 
morphological changes such as phosphatidylserine 
(PS) translocation across the plasma membrane [13], 
accumulation of reactive oxygen species (ROS) in cells 
[14] and loss of mitochondrial membrane potential 
(m) [15]. 
Apoptosis is a tightly regulated, genetically encoded 
process of cell suicide that leads to the clearance of 
dead cells without provoking a potentially damaging 
inflammatory response [12]. Although classically 
recognized for their role in adenosine triphosphate 
(ATP) production, mitochondria are currently regarded 
as central organelles in mediating intrinsic death 
signals and might provide a novel target for new 
chemotherapeutics. Mitochondria were not fully 
appreciated as mediators of apoptosis until it was 
discovered that cytochrome c a mitochondrial protein, 
can activate caspases [4, 16, 17]. Once in the 
cytoplasm, cytochrome c binds Apaf-1 and pro-
caspase 9, leading to the activation of caspase 9 and 
the initiation of the caspases cascade [18].  
In our study we isolated B lymphocytes from CLL 
patients and normal lymphocytes from healthy donors. 
Then we investigated cytotoxic effect of methanolic 
extract of Axinella sinoxea on B lymphocytes obtained 
from CLL patients. Mitochondria as a major pathway 
that can induce apoptosis in cells were studied. 
Therefore the known parameters of mitochondrial 
dysfunction, such as mitochondrial swelling, ROS 
formation, collapse mitochondrial membrane potential 
and cytochrome C release as an initiator of induced 
death on isolated mitochondria from both groups (CLL 
patients and healthy donors) lymphocytes are 
researched.  
2. MATERIALS AND METHODS  
2.1. Sponge Sampling and Identification 
Sponge samples of Axinella Sinoxea were collected 
manually from exposed and semi-exposed habitats, at 
depths of between 0.5 and 14 m, from locations on the 
coast line of Persian Gulf (southern Iran). Taxonomic 
designation was based on scanning electron 
microscope studies and on skeletal slides and 
dissociated spicule mounts. Specimens of all materials 
are deposited in the Department of Fisheries University 
of Hormozgan, Iran [9]. 
2.2. Extract Preparation 
Methanolic extracts were produced by the following 
procedure. Sponge materials were ground together 
with sand and water three times for 30 min. The 
resulting extract (collected after each 30 min) was 
subsequently filtered and freeze- dried. The remaining 
material was sequentially extracted five times with a 
methanol by maceration over 5 days. The resulting 
extract solution was then filtered and concentrated in a 
Rotavapor. For the cytotoxic and mitochondrial assays, 
methanolic extract was suspended in 0.05% Dimethyl 
sulfoxide (DMSO) (v/v) [9]. 
2.3. Selection Healthy Donors or Patients with CLL 
10 CLL patients (6 males and 4 females) aged 54-
65 years were enrolled in this study. CLL was 
diagnosed and confirmed according to definition of the 
World Health Organization (WHO) classification by 
oncologist. Only those patients showing no previous 
treatments within the last 6 months were included in 
the present study. All 10 patients were sampled prior to 
the commencement of any treatment and at least 2 
weeks after the transfusion. Age-matched controls 
were obtained from 10 healthy donors. This study was 
approved by the Shahid Beheshti University of Medical 
Science’s ethics committee and all the patients and 
healthy controls signed an informed consent form [19].  
2.4. Isolation Lymphocytes  
Blood samples were obtained from the CLL patient 
and healthy donors during a routine diagnosis at 
Shohadaye Tajrish Hospital. B lymphocytes were 
isolated immediately using Ficoll gradient 
centrifugation. After 1 h of incubation at 37˚C in 5% 
CO2, adhesive mononuclear cells were removed. 
Those non-adherent lymphocytes were thoroughly 
washed with the Hank's solution. T lymphocytes were 
removed using anti-CD3 dynabeads. The purification of 
B lymphocytes was assessed by flow cytometry with 
anti-CD19 antibodies with FACS (Immunotech, Coulter, 
USA). This cell preparation contained about 95% CD19 
(B lymphocyte antigen) positive cells. It was added 
stromal cell-derived factor-1 to rescue B-lymphocytes 
from apoptosis [19]. 
2.5. Cytotoxicity Assay 
The effect of the methanolic extract of Axinella 
sinoxeais on lymphocytes obtained from healthy 
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donors or patients with CLL was investigated using 
MTT assay. Briefly, the cells were seeded in 96-well 
culture plates at a density of 10,000 cells per well. The 
methanolic extract of Axinella sinoxeais was added to 
various final concentrations (0,100, 250, 500, 1000 and 
2000g/ml) in triplicates. After 24 h of incubation with 
extract, 25 l of MTT reaction solution (5 mg/ml in 
RPMI 1640 medium) was added to the wells. The 
optical density was read at 580 nm wavelength in an 
ELISA plate reader (Tecan, Rainbow Thermo, Austria) 
after 4 h incubation of the plates with MTT in an 
incubator (37 
o
C and 5% CO2 air). All determinations 
were confirmed using replication from at least three 
identical experiments [20]. 
2.6. Cell Lysis and Isolation of Mitochondria 
 Mitochondria were isolated from the lymphocytes 
by mechanical lysis and differential centrifugation. 
Briefly, cells were washed with cold PBS at 4
o
C and 
centrifuged at 1300 RPM. The pellet was resuspended 
in cold isolation buffer (75 mmol/L sucrose, 20 mmol/L 
HEPES, 225 mmol/L mannitol, 0.5 mmol/L EDTA, pH 
7.2), and the cells were disrupted by homogenization. 
Nonlysed cells and nuclei were spun down by 
centrifugation at 1000 g for 10 minutes. The 
supernatant was further spun at 20000 g for 25 
minutes. The pellet, designated as the mitochondrial 
fraction, was suspended in related buffer. The isolation 
of mitochondria was determined by measurement of 
succinate dehydrogenase [21].  
2.7. Determination of Protein Concentration and 
Normalizing Samples 
The Bradford assay is very fast for determination of 
protein concentration. The assay is based on the 
observation that the absorbance maximum for an acidic 
solution of Coomassie Brilliant Blue G-250 shifts from 
465 nm to 595 nm when binding to protein occurs. We 
prepared a standard curve of absorbance versus 
micrograms protein with albumin (0, 500, 1000, 1500 
and 2000 g/ml) and determined amounts from the 
curve. Final concentration of isolated mitochondria was 
adjusted in 1000 g/ml in corresponding buffer [22]. 
2.8. Measurement of Succinate Dehydrogenase 
Briefly, mitochondria obtained from patients and 
healthy donors was suspended in assay buffer (140 
mmol/L KCL, 10 mmol/L NaCl, 2 mmol/L MgCl2, 0.5 
mmol/L KH2PO4, 20 mmol/L HEPES, 0.5 mmol/L 
EGTA; adjusted to pH 7.2 with KOH). The assay buffer 
was supplemented with 1 mg/mL rotenone and 10 
mmol/L succinate immediately before use. The 
mitochondria were seeded in 96-well culture plates at a 
density of 100 g/ml per well. The extract was added to 
various final concentrations (0, 50, 100, 200, 500 and 
1000 g/ml) in triplicates. After 1 h of incubation with 
extract, 25 l of MTT reaction solution (0.4% MTT in 
assay buffer including succinate) was added to the 
wells. The optical density was read at 580 nm 
wavelength in an ELISA plate reader after 30 minutes 
incubation of the plates with MTT in an incubator. All 
determinations were confirmed using replication from at 
least three identical experiments [23].  
2.9. Determination of Mitochondrial ROS in Isolated 
Mitochondria 
The mitochondrial ROS measurement was 
performed using the fluorescent probe DCFH-DA. 
Briefly, isolated mitochondria from both groups of 
lymphocytes and were placed in respiration buffer (0.32 
mM sucrose, 10 mMTris, 20 mM Mops, 50 μM EGTA, 
0.5 mM MgCl2, 0.1 mM KH2PO4 and 5 mM sodium 
succinate ). Following this step, DCFH-DA was added 
(final concentration, 10 μM) to mitochondria and 
following addition of various concentration of extract 
incubated for 10 min. Then, the fluorescence intensity 
of DCF was measured using Shimadzu RF-5000U 
fluorescence spectrophotometer at an excitation 
wavelength of 488 nm and emission wavelength of 527 
nm without 1 hour [24].  
2.10. Determination of the Collapse of 
Mitochondrial Membrane Potential (MMP) 
Mitochondrial uptake of the cationic fluorescent dye, 
rhodamine 123, has been used for the estimation of 
mitochondrial membrane potential. The mitochondrial 
fractions (1000 g protein/mL) were incubated with 10 
μM of rhodamine 123 in MMP assay buffer (220 mM 
sucrose, 68 mM D-mannitol, 10 mMKCl, 5mM KH2PO4, 
2 mM MgCl2, 50 μM EGTA, 5 mM sodium succinate, 10 
mM HEPES, 2 μM Rotenone) and following addition of 
various concentration of extract the fluorescence was 
monitored using Shimadzu RF-5000U fluorescence 
spectrophotometer at the excitation and emission 
wavelength of 490 nm and 535 nm, respectively [25]. 
2.11. Determination of Mitochondrial Swelling 
Purified mitochondria were isolated as described 
above. Mitochondria suspensions (at 100 g protein 
per well) were incubated in 96-well plates at 25
o 
C in 
assay buffer (140 mmol/ L KCl, 10 mmol/L NaCl, 2 
mmol/L MgCl2, 0.5 mmol/L KH2PO4, 20 mmol/L 
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HEPES, 0.5 mmol/L EGTA; adjusted to pH 7.2 with 
KOH) supplemented with 1 mg/mL rotenone and 10 
mmol/L succinate. We added various compounds 
(different concentrations of extract and negative and 
positive controls, separately) after 10 minutes of 
preincubation of mitochondria in swelling buffer. We 
preincubated our isolated mitochondria just to adapt to 
our experimental condition. Mitochondrial swelling was 
measured spectrophotometrically. This method 
equates mitochondrial membrane permeability 
transition with high amplitude swelling of the 
mitochondria. Mitochondrial swelling results in a 
decrease in absorbance monitored at 540 nm [19].  
2.12. Determination of Cytochrome c Release from 
Isolated Mitochondria 
The concentration of cytochrome c was determined 
through using the Quantikine human Cytochrome c 
Immunoassay kit (R&D Systems, Inc., Mineapolis, 
Minn, USA). Briefly, a monoclonal antibody specific for 
human cytochrome c was pre-coated onto the 
microplate. 75 μL of conjugate (containing monoclonal 
antibody specific for cytochrome c conjugated to 
horseradish peroxidase) and 50 μL of control and test 
group were added to each well of the microplate. One 
microgram of protein from each supernatant fraction 
was added to the sample wells. All of the standards, 
controls and test were added to two wells of the 
microplate. After 2 h of incubation, the substrate 
solution (100 μL) was added to each well and 
incubated for 30 min. After this step, 100 μL of the stop 
solution was added to each well; the optical density of 
each well was determined through the aforementioned 
microplate spectrophotometer set to 450 nm [19]. 
2.13. Statistical Analysis 
Results are presented as mean ± SD. Assays were 
performed in triplicate and the mean was used for 
statistical analysis. Statistical significance was 
determined using the one-way ANOVA test, followed 
by the post-hoc Tukey test when appropriate. Statistical 
significance was set at P < 0.05. And the parameters of 
mitochondrial dysfunction were analyzed by two way 
ANOVA and Bonferonie posttest. In all graph were 
expressed as mean ± SEM and P< 0.05 was 
considered statistically significant.  
3. RESULTS  
3.1. Cell Viability  
Determination of the methanolic extract of Axinella 
sinoxeais for potential anti-cancer activity on B 
lymphocytes cells obtained from CLL patients were 
carried out by studying the cytotoxicity effects using the 
MTT assay. All used concentrations decreased cell 
viability in CLL B lymphocytes and concentration of 500 
g/mL resulted in the 50% MTT reduction at 24 hours 
(Figure 1B). Then, the effect of extract on viability of 
normal (lymphocytes) cells was tested. Toxicity 
evaluation in normal lymphocytes revealed no 
significant MTT reduction at the tested concentration 
(Figure 1A). 
 
Figure 1: Effect of the methanolic extract of Axinella sinoxea in both normal (A) and cancerous (B) B lymphocytes on cell 
viability. Cells were treated in with the methanolic extract of Axinella sinoxea is and cell viability was measured by MTT assay at 
24 h. Values were expressed as mean ± SD of three separate determinations (graph A and B).  
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3.2. Succinate Dehydrogenase Activity 
Evaluations of the methanolic extract of sponge 
Axinella sinoxeais for potential activity on mitochondria 
obtained from B lymphocytes of CLL patients and 
normal lymphocytes were carried out by studying its 
inhibitory effects on mitochondrial succinate 
dehydrogenase activity using the MTT assay. The 
methanolic extract of Axinella sinoxeais strongly 
inhibited succinate dehydrogenase activity in a dose-
dependent manner in the cancerous mitochondria, 
obtained from CLL patients at a rang concentration (50- 
1000 g/ml) while only high concentration of 1000 
g/ml influenced succinate dehydrogenase activity on 
normal mitochondria obtained from lymphocytes of 
healthy donors (Figures 2B, 2A). 
3.3. ROS Formation Assay  
We examined whether the level of ROS in both 
cancerous and normal mitochondria were affected by 
the methanolic extract of Axinella sinoxeais with DCFH-
DA staining. As shown in Figure 3B, treatment with the 
methanolic extract of Axinella sinoxeais at 100, 200 
and 500 g/ml in the interval within 1 hour (15, 30, 45, 
60 minutes) significantly increased ROS generation 
 
Figure 2: Effect of the methanolic extract of Axinella sinoxea in both normal (A) and cancerous (B) mitochondria on succinate 
dehydrogenase activity. This figure demonstrates the effect of the methanolic extract of Axinella sinoxea is on succinate 
dehydrogenase activity in both normal and cancerous mitochondria. Mitochondrial succinate dehydrogenase activity was 
measured by MTT assay within 1 h after extract exposure. Values were expressed as mean ± SD of three separate 
determinations (graph A and B).  
 
Figure 3. Effect of the methanolic extract of Axinella sinoxea in both normal (A) and cancerous (B) mitochondria on ROS 
formation. Freshly isolated mitochondria were obtained from both healthy donors and CLL patients incubated with the 
methanolic extract of Axinella sinoxeais for 1 hour in both groups. ROS was measured by DCFH-DA staining with 
spectrofluorescence method. The mean fluorescence intensity was enhanced by extract in comparison to control for each group 
during 1hour after extract addition. Values were expressed as mean ± SD of three separate determinations (graph A and B).  
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(P<0.05) only the in cancerous mitochondria. These 
results suggested that the increasing effect of Axinella 
sinoxeais extract on ROS generation might justify its 
effect on promoting CLL cell apoptosis. However as 
shown at Figure 3A, treatment with the methanolic 
extract of Axinella sinoxea is at 100, 200 and 500 g/ml 
in the interval within 1 hour (15, 30, 45, 60 minutes), 
did not induce significant ROS elevation in normal 
mitochondria. 
3.4. MMP Assay  
To search for the mechanisms involved in 
apoptosis, we examined the effects of the methanolic 
extract of Axinella sinoxea is on membrane 
permeability of mitochondria (m) in isolated 
mitochondria from both groups. The treatment with 
extract (100, 200 and 500 g/ml for 1 hour) showed 
that m decreased only in the mitochondria obtained 
from CLL B lymphocytes in comparison to their 
corresponding control (Figure 4B). Our study on normal 
mitochondria showed that the treatment with extract 
(100, 200 and 500 g/ml for 1 hour) did not induce any 
m collapse in the mitochondria obtained from 
normal B lymphocytes in comparison to their 
corresponding control (Figure 4A). 
 
Figure 4: Effect of the methanolic extract of Axinella sinoxea in both normal (A) and cancerous (B) mitochondria on m. 
Freshly isolated mitochondria from both healthy and CLL cells were treated as indicated above. m was measured 
spectrophotometrically by rhodamine 123 staining with. The presented data revealed that the methanolic extract of Axinella 
sinoxea induced a decrease in m only in cancerous mitochondria obtained from CLL patients (graph B) BUT NOT normal 
lymphocyte mitochondria obtained from healthy donors (graph A). Values were expressed as mean ± SD of three separate 
determinations (graph A and B).  
 
Figure 5: Effect of the methanolic extract of Axinella sinoxea in both normal (A) and cancerous (B) mitochondria on 
mitochondrial swelling. The methanolic extract of Axinella sinoxeais addition (100, 200 and 500 g/ml) induced mitochondrial 
swelling in cancerous But NOT normal lymphocyte mitochondria in a concentration depending manner. Mitochondrial swelling 
suspensions were incubated during for 1 hour. Mitochondrial samples were monitored by following 540 nm absorbance 
decrease every 15 minutes. Values were expressed as mean ± SD of three separate determinations (graph A and B).  
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3.5. Mitochondrial Swelling  
Induction of mitochondrial swelling in mitochondria 
isolated from lymphocytes was monitored by following 
540 nm absorbance. The methanolic extract of Axinella 
sinoxeais addition (100, 200 and 500g/ml) resulted in 
an extensive mitochondrial swelling in cancerous 
mitochondria obtained from B lymphocytes of CLL 
patients (Figure 5B). Addition of the extract to normal 
mitochondria (100, 200 and 500 g/ml) did not result in 
mitochondrial swelling (Figure 5A). 
3.6. Cytochrome c Assay  
Our results showed that the methanolic extract of 
Axinella sinoxea is significantly caused mitochondrial 
swelling and collapse of the mitochondrial membrane 
potential. These events could result in mitochondrial 
permeability transition and release of cytochrome c 
from mitochondria into the cytosolic fraction. As shown 
in Figures 6, the methanolic extract of Axinella sinoxea 
is (200 g/ml) induced significant (P< 0.05) release of 
cytochrome c on the B lymphocyte mitochondria 
isolated from CLL patients but not normal control 
group. Significantly, the pretreatment of the methanolic 
extract of Axinella sinoxea is-treated mitochondria with 
the MPT inhibitor of cyclosporine A (Cs.A) and 
butylated hydroxyl toluene (BHT), an antioxidant, 
inhibited cytochrome c release as compared with The 
methanolic extract of Axinella sinoxea is treated group 
(100 g/ml) (p< 0.05), indicating the role of oxidative 
stress and MPT pore opening in cytochrome c release. 
4. DISCUSSION  
At the last estimate, 80% of the world’s population 
still rely on traditional medicines for their health care 
needs. Without doubt, natural products have been, and 
still are, the cornerstone of the health care medicines 
[10]. Moreover, many organisms, both marine and 
earthly, have developed chemical defense 
mechanisms, secondary metabolites, which allow a 
selective advantage and often have distinct biological 
activities against receptors and enzymes which make 
them ideal candidates for promising pharmacological 
investigation [1]. The most interesting phylum with 
regard to pharmacologically active marine compounds 
include fungi, bacteria, soft corals and gorgonians, sea 
hares and nudibranchs , algae, tunicates, bryozoans 
and sponges [3]. 
Covering around 70% of the planet surface, the 
oceans possess a huge potential for the new discovery 
often on novel molecules [26]. In this report, we 
investigated the effect of marine sponge, Axinella 
sinoxea (collected from the coast line of Bandarabas, 
southern Iran), methanolic extract for selective toxic 
activity on B lymphocytes and their mitochondria 
 
Figure 6: Effect of the methanolic extract of Axinella sinoxea in both normal (A) and cancerous (B) mitochondria on the 
cytochrome c release. As shown in this figure, pretreatment with BHT and CsA significantly inhibited cytochrome c release in the 
cancerous BUT NOT in normal lymphocyte mitochondria. The amount of expelled cytochrome c from mitochondrial fraction into 
the suspension buffer was determined using human Cytochrome c ELISA kit as described above. Values were expressed as 
mean ± SD of three separate determinations. 
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obtained from CLL patients. The results obtained in our 
study showed that the methanolic extract of Axinella 
sinoxea has selective toxicity on cancerous B 
lymphocyte and their mitochondria and these effects 
are depended on concentration and time (data not 
shown) (Figures 1 and 2).  
Our findings on mitochondria isolated from B 
lymphocytes of CLL patients showed that ROS 
formation increased following addition of methanolic 
extract of Axinella sinoxea in cancerous mitochondria 
(Figure 3B) while such a effect has not been observed 
on normal mitochondria (Figure 3A). Elevated ROS 
levels in tumor cells compared to normal cells has been 
exploited experimentally to kill cancer cells specifically 
by chemically pushing ROS levels over a critical 
homeostatic threshold that is incompatible with either 
growth or survival of tumor cells but tolerable by normal 
cells [27]. Indeed, many current anti-tumor agents used 
in the clinic, such as cisplatin and certain alkaloids, rely 
on ROS production for their efficacy [13, 28, 29]. MMP 
is a universal feature of cell death and is often 
considered as the “point of no return” in the cascade of 
events leading to apoptosis [30]. Shortly after the 
discovery that MMP is frequently impaired in cancer, 
mitochondria have become an attractive target to 
induce apoptosis and to overcome resistance to 
chemotherapy [31-33]. Currently, more than 20 
mitochondrion-targeted compounds have been 
reported to induce apoptosis selectively in malignant 
cell lines, and some of these already being used in 
phase II/III clinical trials or validated in vitro in pre-
clinical settings [31, 34]. These compounds can be 
classified according to their chemical nature into three 
main groups: peptide derivatives (Bax 106–134), small 
molecules (Arsenic trioxide), and cationic lipophilic 
agents (rhodamine 123). Tested extract at this study 
had shown that it selectively caused MMP in cancerous 
but not normal mitochondria (Figure 4). ROS induced 
promotion of Ca
2
 dependent mitochondrial permeability 
transition (MPT), with swelling of the mitochondrial 
matrix and rupture of the OMM [35, 36] resulted from 
swelling assay on isolated CLL mitochondria proved 
again that mitochondrial swelling occurs only in 
cancerous but not normal mitochondria following the 
addition of methanolic extract of Axinella sinoxea 
(Figure 5). The mitochondrial respiratory chain on the 
inner mitochondrial membrane (IMM) is a major 
intracellular source of reactive oxygen species (ROS). 
Many studies have connected mitochondrial 
dysfunction caused by ROS with both apoptotic and 
necrotic cell death [37]. ROS may promote MPT by 
causing oxidation of thiol groups on the adenine 
nucleotide translocator [31, 38]. Reactive oxygen 
species (ROS) play a key role in promoting 
mitochondrial cytochrome c release and induction of 
apoptosis. ROS induce dissociation of cytochrome c 
from cardiolipin on the inner mitochondrial membrane 
(IMM), and cytochrome c may then be released via 
mitochondrial permeability transition (MPT)-dependent 
or MPT-independent mechanisms. In our study we 
showed that cytochrome C release from cancerous 
mitochondria occurred following their exposure to 
extract (Figure 6). Stimuli triggering apoptosis through 
mitochondria pathway, resulting in the release of 
cytochrome c (Cyt c) from the mitochondrial 
intermembrane space (IMS) into cytoplasm and 
activation of downstream effector caspases [39]. Finally 
we suggest that the methanolic extract of Axinella 
sinoxea contains anti-cancer compounds which could 
induce apoptosis through mitochondria pathway with 
increasing ROS production and oxidative stress in 
cancerous B lymphocytes isolated from CLL patients.  
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